87
Participants
Start Date
March 31, 2023
Primary Completion Date
June 30, 2026
Study Completion Date
September 30, 2026
NanO2TM
0.1 mL/kg NanO2 infusion
Placebo Saline Infusion
Saline Infusion
Inova Schar Cancer Institute, Fairfax
Duke University Medical Center, Durham
University Hospitals Seidman Cancer Center, Cleveland
St. Francis Medical Center, OSF Healthcare, Peoria
Saint Luke's Cancer Institute, Kansas City
Ochsner Clinic Foundation, New Orleans
Center for Neurosciences, Tucson
University of Arizona, Tucson
Providence St. John's Cancer Institute, Santa Monica
UC Irvine Health- Chao Family Comprehensive Cancer Center, Orange
Yale Cancer Center, New Haven
Atlantic Health System, Summit
NuvOx LLC
INDUSTRY